The documents are submitted to the U.S. Food and Drug Administration (FDA). The concern has also sent applications for registration of the vaccine to other countries, including Australia, Great Britain, Europe, Canada, and Japan.
According to current forecasts, companies plan to produce up to 50 million doses of the vaccine in 2020 and up to 1.3 billion doses by the end of 2021. However, Biontech and Pfizer said that they were ready to distribute the vaccine within a few hours after the vaccine was registered.
"Ukraine is ready. We also have refrigeration units that can store the vaccine at -70 degrees celsius," the minister commented.